Institute for Wealth Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$122K Buy
+1,913
New +$126K 0.01% 635
2025
Q3
– Sell
-2,724
Closed -$202K – 576
2025
Q2
$202K Sell
2,724
-155
-5% -$10.8K 0.02% 540
2025
Q1
$232K Sell
2,879
-154
-5% -$13.2K 0.03% 478
2024
Q4
$237K Sell
3,033
-143
-5% -$12.2K 0.03% 454
2024
Q3
$298K Sell
3,176
-48
-1% -$4.03K 0.04% 415
2024
Q2
$251K Sell
3,224
-134
-4% -$10.9K 0.03% 426
2024
Q1
$305K Buy
3,358
+1
+0% +$83 0.04% 385
2023
Q4
$260K Sell
3,357
-134
-4% -$9.38K 0.04% 401
2023
Q3
$238K Sell
3,491
-20
-0.6% -$1.46K 0.04% 396
2023
Q2
$285K Sell
3,511
-220
-6% -$17.6K 0.05% 372
2023
Q1
$306K Buy
+3,731
New +$266K 0.06% 346

Other funds holding GEHC

Institute for Wealth Management's GEHC Position: Q2 2026 in Review

Institute for Wealth Management opened a new position in GE HealthCare (GEHC) in Q2 2026: 1,913 shares worth $122K. The stake represents 0.01% of the portfolio and ranks #635 among its holdings. This is a return to the name: Institute for Wealth Management previously reported a position in GEHC as recently as Q2 2025.

Institute for Wealth Management first reported a position in GEHC in Q1 2023 and has held it in 11 quarters since. The position peaked at $306K in Q1 2023. 1,233 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Institute for Wealth Management held 1,913 shares of GE HealthCare worth $122K as of Q2 2026.
  • GE HealthCare was a new Institute for Wealth Management position in Q2 2026.
  • GE HealthCare made up 0.01% of Institute for Wealth Management's portfolio in Q2 2026, its #635 holding.
  • Institute for Wealth Management first reported a position in GE HealthCare in Q1 2023 and has held it in 11 quarters since.
  • Institute for Wealth Management's GE HealthCare position peaked at $306K in Q1 2023.
  • 1,233 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Institute for Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.